Media information: Sanofi Toujeo medical treatment
SWITCHING TO TOUJEO® IN A REAL-WORLD SETTING PRODUCED A SIMILAR NUMBER OF SEVERE LOW BLOOD SUGAR EVENTS AS INSULIN DEGLUDEC
Adults with type 2 diabetes who switched their basal insulin therapy to Toujeo® or insulin degludec, experienced similar numbers of low blood sugar (hypoglycemia) events, according to the findings of two comparative real-world studies. Patients also experienced similar reduction of average blood sugar (HbA1c) with the different insulin treatments.
- Health & Medicine
- Men's Health
- Women's Health